
About Park Hospital
Park Hospital is a publicly listed company based in Delhi (India) founded in 1982 by Ajit Gupta. Park Hospital offers multi-specialty healthcare services across North Indian locations. It operates on a B2C and B2B model. The company has 102 employees. Park Hospital has completed 2 acquisitions, including Nidaan Hospital and RGS Healthcare. Its website parkhospital.in draws about 41 thousand monthly visits. Its Indian entity Park Medi World Limited reported revenue of βΉ1,711 Cr. Park Hospital offers products and services including Multi-Specialty Hospitals, Cardiac Sciences, and Neurosciences. Its focus areas include Medical Services, Specialized Treatments, Cardiac and Surgical and Hospitals. Similar companies include Fortis Healthcare, Ujala Cygnus and Narayana Health; 2 of its 3 listed similar companies have raised funding.
Company details
Park Hospital operates as a chain of multi-specialty hospitals in North India, providing advanced medical services such as cardiac care, neurosciences, and surgical specialties. It has 13 NABH-accredited facilities in states like Delhi, Haryana, and Rajasthan, offering emergency services, diagnostics, and treatments for various ailments. The group focuses on quality healthcare through specialized centers and supports patients with physiotherapy and blood bank services.
- Headquarters Delhi, India
- Employees 102
- Founders Ajit Gupta
- Stage Public
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website parkhospital.in
- Social LinkedIn X Facebook
- Legal Name Park Medi World Limited
- Market Cap₹9,556 Cr
PARKHOSPS · NSE
- Share Price₹219.70
-0.70% today
- Revenue₹1,679 Cr
FY 2025-26 · +20.5% YoY
- EBITDA₹446 Cr
Margin 26.6%
- Net Profit₹258 Cr
FY 2025-26 · +27.1% YoY
- P/E (TTM)35.3x
P/B 4.9x
- ROE17.9%
ROCE 20.2%
- Debt / Equity0.34
Interest cover 15.9x
- Employee Count102
- Investments & AcquisitionsNidaan Hospital
& 1 more
Associated legal entities of Park Hospital
Park Hospital is associated with 5 registered companies on The Company Check; the primary company is Park Medi World Limited, a listed company. Each company page carries the filings, financials, charges and directors of that entity.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2026) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Park Medi World Limited Listed CIN L85110DL2011PLC212901 | Active | 20 Jan 2011 | New Delhi, Delhi | ₹1,711 Cr | 105 | 9 | View details |
| Park Medi World Private Limited CIN U85110DL2011PLC212901 | Active | 20 Jan 2011 | New Delhi, Delhi, India | View details | |||
| Park Medicity India Private Limited CIN U85110DL2010PTC204598 | Active | 24 Jun 2010 | New Delhi, Delhi | ₹122 Cr | 144 | 5 | View details |
| Park Medicity (Haryana) Private Limited CIN U74999DL2014PTC270072 | Active | 07 Aug 2014 | New Delhi, Delhi | ₹2.5 Cr | 23 | 2 | View details |
| Alpha Medical Services Pvt. Ltd. CIN U85110WB1994PTC061512 | Active | 20 Jan 1994 | Howrah, West Bengal | ₹2.2 Cr | 12 | 2 | View details |
Products & Services of Park Hospital
Park Hospital offers a comprehensive portfolio of products and services, including Multi-Specialty Hospitals, Cardiac Sciences, and Neurosciences.
Offers comprehensive medical care and emergency treatments
Provides advanced heart disease diagnosis and surgery
Delivers brain and spine treatment services
Board of directors of Park Medi World Limited (Park Hospital)
Park Medi World Limited is the primary company behind Park Hospital. The boards of the 4 registered companies of Park Hospital currently have 12 directors; the longest-serving is Vijay Kumar Kejriwal, appointed in 1994. 21 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Vijay Kumar Kejriwal DIN 00482055 | Director | 20 Jan 1994 | 32 yrs 9 mo | Alpha Medical Services Pvt. Ltd. |
| Sushma Kejriwal DIN 00481862 | Director | 20 Jan 1994 | 32 yrs 9 mo | Alpha Medical Services Pvt. Ltd. |
| Ajit Gupta DIN 02865369 | Director | 24 Jun 2010 | 16 yrs 4 mo | Park Medicity India Private Limited, Park Medi World Limited |
| Ajit Kumar Srivastava DIN 08422561 | CEO | 22 Jun 2023 | 3 yrs 4 mo | Park Medicity India Private Limited |
| Ravi Krishan Takkar DIN 07734571 | Director | 06 May 2024 | 2 yrs 5 mo | Park Medi World Limited |
| Munish Sibal DIN 09446728 | Director | 31 May 2024 | 2 yrs 5 mo | Park Medi World Limited |
| Rajesh Sharma DIN 02726305 | Director | 10 Jul 2024 | 2 yrs 3 mo | Park Medicity India Private Limited |
| Ankit Gupta DIN 02865321 | Managing Director | 10 Jul 2024 | 2 yrs 3 mo | Park Medi World Limited |
| Kamlesh Kohli DIN 09446586 | Director | 13 Nov 2024 | 1 yr 11 mo | Park Medicity India Private Limited, Park Medi World Limited |
| Manju Sharma DIN 10311342 | Director | 14 Nov 2024 | 1 yr 11 mo | Park Medicity (Haryana) Private Limited |
| Sanjay Sharma DIN 07181328 | Director | 14 Nov 2024 | 1 yr 11 mo | Park Medicity (Haryana) Private Limited, Park Medi World Limited |
| Sudesh Kumar Sharma DIN 03592723 | Director | 29 Sep 2025 | 1 yr 1 mo | Park Medicity India Private Limited |
People of Park Hospital
11 people are tracked at Park Hospital (5 in leadership, 6 in team); the tracked headcount is 102.
| Name | Role | Group |
|---|---|---|
| Founder | Leadership | |
Prem Kakar | Chief Executive Officer | Leadership |
Dr Ajit Srivastava | Group Medical Director | Leadership |
Varun Jha | Deputy General Manager Operations | Leadership |
Sanit Bahri | Group General Manager International Business | Leadership |
Manoj Dahiya | Operations Executive | Team |
Manisha Yadav | Operation Executive | Team |
Monika Sharma | Operations Manager | Team |
Nazia Rehman | Cheif Operating Officer | Team |
Ashutosh Pant | AGM Operations | Team |
Manjeet Singh | Operations Manager | Team |
Complete people profiles for Park Hospital
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Park Hospital
Park Hospital is a publicly listed company on the BSE with ticker symbol PARKHOSPS in India, operating in the Health services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date17 Dec 2025
- Listed onBSE: 544645 · NSE: PARKHOSPS
- Listed entityPark Medi World Limited
- Exchange sectorHealth services
- ISININE119201023
- Share price₹259.35 (+4.05% on the day) · 2026-05-11
- Market capitalisation₹10,779 Cr
- Volume (last session)170,885
- Analyst consensusStrong buy
Financials of Park Hospital
Exchange-reported figures of Park Medi World Limited, the listed company behind Park Hospital (NSE: PARKHOSPS).
Financial Highlights
FY 2025-26 Β· ConsolidatedRevenue vs Net Profit ₹ Cr
Margin trends
Financial summary ₹ Cr
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Income statement | ||||||
| Revenue | 1,679 | 1,394 | 1,231 | 1,255 | 1,084 | 766 |
| Revenue growth | +20.5% | +13.2% | -1.9% | +15.7% | +41.6% | - |
| EBITDA | 446 | 372 | 309 | 389 | 344 | 309 |
| EBITDA margin | +26.6% | +26.7% | +25.1% | +31.0% | +31.8% | +40.4% |
| Profit before tax | 355 | 286 | 218 | 315 | 278 | 265 |
| Net profit | 258 | 203 | 155 | 221 | 181 | 155 |
| Net profit margin | +15.4% | +14.6% | +12.6% | +17.6% | +16.7% | +20.2% |
| EPS (βΉ) | 5.98 | 5.25 | 9.98 | 14.29 | 11.76 | 80.54 |
| Balance sheet | ||||||
| Total assets | 2,482 | 1,812 | 1,630 | 1,311 | 1,065 | 642 |
| Net worth | 2,022 | 1,052 | 883 | 687 | 457 | 275 |
| Total debt | 364 | 682 | 687 | 576 | 517 | 292 |
| Cash & bank | 431 | 361 | 390 | 203 | 192 | 89.42 |
| Net working capital | 773 | 718 | 705 | 580 | 503 | 258 |
| Cash flow | ||||||
| Cash from operations | 329 | 215 | 367 | 199 | 155 | 223 |
| Cash from investing | (316) | (100) | (76.29) | (234) | (248) | (233) |
| Cash from financing | 121 | (88.86) | (130) | 1.04 | 163 | 49.47 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 476 | 460 | 410 | 410 | 399 | 354 | 348 |
| Revenue growth (YoY) | +19.3% | +30.1% | +17.8% | - | - | - | - |
| Other income | 7.65 | 7.50 | 9.10 | 8.03 | 6.87 | 8.57 | 14.76 |
| EBITDA | 126 | 127 | 99.41 | 113 | 105 | 88.43 | 82.81 |
| EBITDA margin | +26.5% | +27.7% | +24.2% | +27.5% | +26.3% | +25.0% | +23.8% |
| Depreciation | 18.84 | 17.51 | 15.30 | 14.89 | 14.77 | 15.53 | 15.03 |
| Interest | 9.81 | 13.98 | 14.95 | 14.53 | 15.13 | 15.65 | 15.73 |
| Profit before tax | 105 | 103 | 78.26 | 91.35 | 81.91 | 65.82 | 66.81 |
| Tax | 16.49 | 26.62 | 25.42 | 12.82 | 16.39 | 13.48 | 21.16 |
| Net profit | 88.60 | 76.75 | 52.84 | 78.53 | 65.52 | 52.34 | 45.65 |
| EPS (βΉ) | 2.05 | 1.78 | 1.35 | 2.04 | 1.70 | 1.36 | 1.19 |
| Metrics | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | 129 | 91.58 | 89.56 | 102 | 110 |
| Revenue growth | +40.8% | +2.3% | -12.6% | -6.8% | - |
| EBITDA | 52.44 | 24.14 | 25.68 | 23.87 | 20.69 |
| EBITDA margin | +40.7% | +26.4% | +28.7% | +23.3% | +18.8% |
| Profit before tax | 45.45 | 8.90 | 12.52 | 10.44 | 12.60 |
| Net profit | 36.62 | 7.21 | 7.50 | 7.11 | 8.35 |
| Net profit margin | +28.4% | +7.9% | +8.4% | +6.9% | +7.6% |
| EPS (βΉ) | 0.85 | 0.19 | 0.49 | 0.46 | 0.54 |
| Balance sheet | |||||
| Total assets | 880 | 287 | 249 | 231 | 197 |
| Net worth | 860 | 114 | 106 | 100 | 97.71 |
| Total debt | 18.89 | 168 | 125 | 114 | 98.72 |
| Cash & bank | 89.41 | 5.51 | 4.29 | 8.61 | 10.88 |
| Net working capital | 306 | 17.39 | 4.72 | 27.81 | 63.60 |
| Cash flow | |||||
| Cash from operations | 17.42 | 4.66 | 48.10 | 45.42 | (10.24) |
| Cash from investing | (481) | (28.19) | (51.49) | (39.44) | 19.11 |
| Cash from financing | 547 | 24.93 | (4.63) | (0.93) | (9.09) |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 33.53 | 27.43 | 45.87 | 32.69 | 22.97 | 23.26 | 22.76 |
| Revenue growth (YoY) | +46.0% | +17.9% | +101.5% | - | - | - | - |
| Other income | 4.67 | 8.27 | 5.52 | 0.28 | 0.20 | 0.98 | 0.31 |
| Total expenses | 32.25 | 22.66 | 27.85 | 17.40 | 12.62 | 15.37 | 18.08 |
| EBITDA | 1.28 | 4.77 | 18.02 | 15.29 | 10.35 | 7.89 | 4.68 |
| EBITDA margin | +3.8% | +17.4% | +39.3% | +46.8% | +45.1% | +33.9% | +20.6% |
| Depreciation | 3.38 | 1.01 | 1.18 | 1.16 | 1.16 | 1.33 | 1.30 |
| Interest | 0.86 | 2.42 | 3.61 | 3.43 | 3.30 | 3.17 | 3.14 |
| Profit before tax | 1.71 | 9.61 | 18.75 | 10.98 | 6.09 | 4.37 | 0.55 |
| Tax | 0.62 | 1.01 | 4.20 | 2.43 | 1.20 | 0.89 | 0.36 |
Financial Statements
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 476 | 460 | 410 | 410 | 399 | 354 | 348 |
| Revenue growth (YoY) | +19.3% | +30.1% | +17.8% | - | - | - | - |
| Other income | 7.65 | 7.50 | 9.10 | 8.03 | 6.87 | 8.57 | 14.76 |
| EBITDA | 126 | 127 | 99.41 | 113 | 105 | 88.43 | 82.81 |
| EBITDA margin | +26.5% | +27.7% | +24.2% | +27.5% | +26.3% | +25.0% | +23.8% |
| Depreciation | 18.84 | 17.51 | 15.30 | 14.89 | 14.77 | 15.53 | 15.03 |
| Interest | 9.81 | 13.98 | 14.95 | 14.53 | 15.13 | 15.65 | 15.73 |
| Profit before tax | 105 | 103 | 78.26 | 91.35 | 81.91 | 65.82 | 66.81 |
| Tax | 16.49 | 26.62 | 25.42 | 12.82 | 16.39 | 13.48 | 21.16 |
| Net profit | 88.60 | 76.75 | 52.84 | 78.53 | 65.52 | 52.34 | 45.65 |
| EPS (βΉ) | 2.05 | 1.78 | 1.35 | 2.04 | 1.70 | 1.36 | 1.19 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Revenue | 1,679 | 1,394 | 1,231 | 1,255 | 1,084 | 766 |
| Revenue growth | +20.5% | +13.2% | -1.9% | +15.7% | +41.6% | - |
| Other income | 31.61 | 32.41 | 32.02 | 17.58 | 9.57 | 3.49 |
| Total expenses | 1,233 | 1,022 | 923 | 865 | 740 | 457 |
| Employee cost | 323 | 276 | 232 | 218 | 137 | 69.09 |
| EBITDA | 446 | 372 | 309 | 389 | 344 | 309 |
| EBITDA margin | +26.6% | +26.7% | +25.1% | +31.0% | +31.8% | +40.4% |
| Depreciation | 62.46 | 56.90 | 50.57 | 40.52 | 35.07 | 23.61 |
| Interest | 60.86 | 61.85 | 71.83 | 51.15 | 40.46 | 24.34 |
| Profit before tax | 355 | 286 | 218 | 315 | 278 | 265 |
| Tax | 81.03 | 70.23 | 66.15 | 86.84 | 78.99 | 67.80 |
| Net profit | 258 | 203 | 155 | 221 | 181 | 155 |
| Net profit margin | +15.4% | +14.6% | +12.6% | +17.6% | +16.7% | +20.2% |
| EPS (βΉ) | 5.98 | 5.25 | 9.98 | 14.29 | 11.76 | 80.54 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Equity & liabilities | ||||||
| Share capital | 86.39 | 76.88 | 76.88 | 76.88 | 76.88 | 19.22 |
| Reserves & surplus | 1,936 | 975 | 806 | 610 | 380 | 256 |
| Shareholders' funds (net worth) | 2,022 | 1,052 | 883 | 687 | 457 | 275 |
| Minority interest | 82.31 | 66.77 | 52.71 | 43.41 | 87.20 | 70.39 |
| Secured loans | 226 | 600 | 612 | 556 | 503 | 285 |
| Unsecured loans | 139 | 82.17 | 74.56 | 19.27 | 14.90 | 7.37 |
| Total debt | 364 | 682 | 687 | 576 | 517 | 292 |
| Total liabilities | 2,482 | 1,812 | 1,630 | 1,311 | 1,065 | 642 |
| Assets | ||||||
| Gross block | 1,541 | 1,049 | 997 | 606 | 492 | 462 |
| Net block | 1,309 | 890 | 837 | 536 | 458 | 365 |
| Capital work in progress | 123 | 37.09 | 31.70 | 4.90 | 28.96 | 7.48 |
| Investments | 0.13 | 0.09 | 0.09 | 0.00 | 0.00 | 0.00 |
| Inventories | 2.90 | 2.54 | 2.20 | 1.68 | 6.00 | 8.08 |
| Sundry debtors | 593 | 614 | 511 | 576 | 449 | 316 |
| Cash & bank balances | 431 | 361 | 390 | 203 | 192 | 89.42 |
| Loans & advances | 60.02 | 57.01 | 83.94 | 80.90 | 76.27 | 17.43 |
| Total current assets | 1,088 | 1,034 | 987 | 862 | 724 | 431 |
| Total current liabilities | 315 | 315 | 282 | 281 | 221 | 173 |
| Net working capital | 773 | 718 | 705 | 580 | 503 | 258 |
| Total assets | 2,482 | 1,812 | 1,630 | 1,311 | 1,065 | 642 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Opening cash | 103 | 76.63 | 117 | 151 | 80.91 | 44.16 |
| Net cash from operating activities | 329 | 215 | 367 | 199 | 155 | 223 |
| Net cash from investing activities | (316) | (100) | (76.29) | (234) | (248) | (233) |
| Net cash from financing activities | 121 | (88.86) | (130) | 1.04 | 163 | 49.47 |
| Net change in cash | 134 | 26.38 | 161 | (34.15) | 69.79 | 39.09 |
| Closing cash | 431 | 361 | 390 | 203 | 192 | 89.42 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|---|
| Growth | ||||||
| Sales growth | +20.5% | +13.2% | -1.9% | +15.7% | +41.6% | - |
| EBITDA growth | +20.0% | +20.6% | -20.7% | +13.0% | +11.3% | - |
| PBT growth | +24.1% | +30.9% | -30.7% | +13.2% | +5.1% | +9997.0% |
| Net income growth | +27.1% | +31.3% | -30.1% | +22.3% | +16.9% | - |
| Revenue CAGR (3Y) | +10.2% | +8.7% | +17.1% | - | - | - |
| EBITDA CAGR (3Y) | +4.7% | +2.6% | -0.1% | - | - | - |
| Profitability & leverage | ||||||
| Net income margin | +16.3% | +15.5% | +12.4% | +18.2% | +18.4% | +25.7% |
| Return on capital employed | +20.2% | +21.1% | +20.6% | +33.0% | +41.8% | +51.7% |
| Return on net worth | +17.9% | +22.6% | +19.7% | +40.8% | +56.4% | +75.0% |
| Debt / equity | 0.34 | 0.72 | 0.82 | 0.98 | 1.14 | 1.11 |
| Long-term debt / equity | 0.20 | 0.47 | 0.50 | 0.64 | 0.84 | 0.79 |
| Interest cover | 15.86 | 19.63 | 27.84 | 14.67 | 13.08 | 8.52 |
| Efficiency & per share | ||||||
| Fixed asset turnover | 1.31 | 1.38 | 1.56 | 2.34 | 2.33 | 1.70 |
| Inventory turnover | 617.41 | 588.00 | 634.57 | 326.72 | 154.03 | 94.79 |
| Debtors turnover | 2.78 | 2.48 | 2.26 | 2.45 | 2.83 | 2.42 |
| EPS (βΉ) | 5.98 | 5.25 | 9.98 | 14.29 | 11.76 | 80.54 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 46.54 | 27.06 | 56.64 | 43.87 | 28.93 | 136.77 |
| Particulars | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | 33.53 | 27.43 | 45.87 | 32.69 | 22.97 | 23.26 | 22.76 |
| Revenue growth (YoY) | +46.0% | +17.9% | +101.5% | - | - | - | - |
| Other income | 4.67 | 8.27 | 5.52 | 0.28 | 0.20 | 0.98 | 0.31 |
| Total expenses | 32.25 | 22.66 | 27.85 | 17.40 | 12.62 | 15.37 | 18.08 |
| EBITDA | 1.28 | 4.77 | 18.02 | 15.29 | 10.35 | 7.89 | 4.68 |
| EBITDA margin | +3.8% | +17.4% | +39.3% | +46.8% | +45.1% | +33.9% | +20.6% |
| Depreciation | 3.38 | 1.01 | 1.18 | 1.16 | 1.16 | 1.33 | 1.30 |
| Interest | 0.86 | 2.42 | 3.61 | 3.43 | 3.30 | 3.17 | 3.14 |
| Profit before tax | 1.71 | 9.61 | 18.75 | 10.98 | 6.09 | 4.37 | 0.55 |
| Tax | 0.62 | 1.01 | 4.20 | 2.43 | 1.20 | 0.89 | 0.36 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Revenue | 129 | 91.58 | 89.56 | 102 | 110 |
| Revenue growth | +40.8% | +2.3% | -12.6% | -6.8% | - |
| Other income | 10.34 | 2.07 | 5.15 | 4.63 | 14.85 |
| Total expenses | 76.53 | 67.44 | 63.88 | 78.57 | 89.24 |
| Employee cost | 18.75 | 17.23 | 15.71 | 17.99 | 14.80 |
| EBITDA | 52.44 | 24.14 | 25.68 | 23.87 | 20.69 |
| EBITDA margin | +40.7% | +26.4% | +28.7% | +23.3% | +18.8% |
| Depreciation | 4.51 | 4.86 | 4.63 | 4.89 | 3.00 |
| Interest | 12.82 | 12.45 | 13.68 | 13.17 | 19.94 |
| Profit before tax | 45.45 | 8.90 | 12.52 | 10.44 | 12.60 |
| Tax | 8.83 | 1.73 | 5.02 | 3.33 | 4.25 |
| Net profit | 36.62 | 7.21 | 7.50 | 7.11 | 8.35 |
| Net profit margin | +28.4% | +7.9% | +8.4% | +6.9% | +7.6% |
| EPS (βΉ) | 0.85 | 0.19 | 0.49 | 0.46 | 0.54 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Equity & liabilities | |||||
| Share capital | 86.39 | 76.88 | 76.88 | 76.88 | 76.88 |
| Reserves & surplus | 774 | 37.31 | 29.59 | 23.52 | 20.83 |
| Shareholders' funds (net worth) | 860 | 114 | 106 | 100 | 97.71 |
| Secured loans | 9.74 | 85.66 | 105 | 114 | 92.58 |
| Unsecured loans | 9.15 | 82.74 | 20.50 | 0.00 | 6.14 |
| Total debt | 18.89 | 168 | 125 | 114 | 98.72 |
| Total liabilities | 880 | 287 | 249 | 231 | 197 |
| Assets | |||||
| Gross block | 89.43 | 88.52 | 81.94 | 38.66 | 44.13 |
| Net block | 70.98 | 74.58 | 72.60 | 33.77 | 20.28 |
| Capital work in progress | 106 | 37.02 | 13.13 | 5.29 | 8.23 |
| Investments | 382 | 149 | 149 | 148 | 102 |
| Inventories | 0.46 | 0.06 | 0.08 | 0.09 | 0.16 |
| Sundry debtors | 38.89 | 33.32 | 22.14 | 35.56 | 44.42 |
| Cash & bank balances | 89.41 | 5.51 | 4.29 | 8.61 | 10.88 |
| Loans & advances | 214 | 11.36 | 6.73 | 27.26 | 39.67 |
| Total current assets | 343 | 50.25 | 33.24 | 71.52 | 95.13 |
| Total current liabilities | 36.64 | 32.86 | 28.52 | 43.71 | 31.53 |
| Net working capital | 306 | 17.39 | 4.72 | 27.81 | 63.60 |
| Total assets | 880 | 287 | 249 | 231 | 197 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Opening cash | 1.98 | 0.59 | 8.61 | 3.55 | 3.77 |
| Net cash from operating activities | 17.42 | 4.66 | 48.10 | 45.42 | (10.24) |
| Net cash from investing activities | (481) | (28.19) | (51.49) | (39.44) | 19.11 |
| Net cash from financing activities | 547 | 24.93 | (4.63) | (0.93) | (9.09) |
| Net change in cash | 83.50 | 1.40 | (8.02) | 5.06 | (0.22) |
| Closing cash | 89.41 | 5.51 | 4.29 | 8.61 | 10.88 |
| Particulars | FY 2025-26 | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|---|
| Growth | |||||
| Sales growth | +40.8% | +2.3% | -12.6% | -6.8% | - |
| EBITDA growth | +117.2% | -6.0% | +7.6% | +15.4% | - |
| PBT growth | +410.7% | -28.9% | +19.9% | -17.1% | +9997.0% |
| Net income growth | +407.9% | -3.9% | +5.5% | -14.9% | - |
| Revenue CAGR (3Y) | +8.0% | -5.9% | - | - | - |
| EBITDA CAGR (3Y) | +30.0% | +5.3% | - | - | - |
| Profitability & leverage | |||||
| Net income margin | +28.4% | +7.8% | +8.4% | +6.9% | +7.6% |
| Return on capital employed | +10.0% | +8.0% | +10.9% | +11.0% | +16.5% |
| Return on net worth | +7.5% | +6.5% | +7.3% | +7.2% | +8.6% |
| Debt / equity | 0.19 | 1.33 | 1.16 | 1.07 | 1.01 |
| Long-term debt / equity | 0.07 | 0.43 | 0.33 | 0.55 | 0.77 |
| Interest cover | 26.75 | 64.57 | 64.99 | 69.39 | 112.72 |
| Efficiency & per share | |||||
| Fixed asset turnover | 1.45 | 1.07 | 1.49 | 2.47 | 2.49 |
| Inventory turnover | 496.04 | 1,308.29 | 1,053.65 | 819.52 | 687.06 |
| Debtors turnover | 3.57 | 3.30 | 3.10 | 2.56 | 2.47 |
| EPS (βΉ) | 0.85 | 0.19 | 0.49 | 0.46 | 0.54 |
| Dividend per share (βΉ) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Book value per share (βΉ) | 19.91 | 2.97 | 6.92 | 6.53 | 6.35 |
Investments & Acquisitions by Park Hospital
Park Hospital has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Nidaan Hospital and RGS Healthcare.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Healthcare services are provided by RGS Healthcare. | rgshealthcare.com | 0 | May 2023 | β’β’β’β’ | ||
Multi-specialty medical services are delivered in Sonipat, India. | nidaanhospital.com | Sonipat, India | 1983 | Jul 2021 | β’β’β’β’ |
Complete acquisition details for Park Hospital
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Park Hospital
4 dated milestones of Park Hospital across 43 years, from founding to its latest funding, stage changes and deals.
- Founded Park Hospital is founded.
- Acquisition Acquires Nidaan Hospital.
- Acquisition Acquires RGS Healthcare.
- IPO Lists on the stock exchange (IPO).
Similar companies to Park Hospital
Park Hospital has 3 listed similar companies in our database, 2 of them funded. They include Fortis Healthcare, Ujala Cygnus and Narayana Health.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| fortishealthcare.com | 1996 | Gurugram, India | 1,565 | Multi-specialty hospital services are provided across India by Fortis Healthcare. | ||
| ujalacygnus.com | 2011 | Delhi, India | $36.74M | 2,084 | A chain of multi-specialty hospitals is operated in India. | |
| narayanahealth.org | 2000 | Bengaluru, India | $148.2M | 8,145 | A chain of multi-specialty hospitals is operated in India. |
Detailed similar companies of Park Hospital
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Park Hospital
The website of Park Hospital (parkhospital.in) receives about 41.1K visits a month.
- Monthly visits41.1K
▼ 8.9% vs previous month
Websites whose visitors overlap most with Park Hospital. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
venkateshwarhospitals.com | venkateshwarhospitals.com | 100% | #361,241 | β | |
| rghospitals.com | 96% | 83.1K | #430,601 | View details | |
| doctorsfinder.in | 95% | #1,739,909 | View details | ||
| sarojhospital.com | 95% | 6.5K | #2,987,471 | View details | |
| artemishospitals.com | 95% | 56.5K | #583,193 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 40 similar websites and full traffic analytics for Park Hospital
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Park Hospital
Complete news archive for Park Hospital
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Park Hospital
Park Hospital was founded in 1982.
Park Hospital is headquartered in Delhi, India. It is registered at Delhi, Delhi, India.
Park Hospital has 102 employees.
The primary company behind Park Hospital, Park Medi World Limited, reported revenue of βΉ1,711 Cr for FY 2026, up 21% year on year.
Park Hospital operates as a chain of multi-specialty hospitals in North India, providing advanced medical services such as cardiac care, neurosciences, and surgical specialties. It has 13 NABH-accredited facilities in states like Delhi, Haryana, and Rajasthan, offering emergency services, diagnostics, and treatments for various ailments. The group focuses on quality healthcare through specialized centers and supports patients with physiotherapy and blood bank services.
Park Hospital's top competitors include Fortis Healthcare, Ujala Cygnus and Narayana Health.
Park Hospital offers Multi-Specialty Hospitals, Cardiac Sciences, and Neurosciences.
Yes, Park Hospital is publicly traded on BSE under the ticker symbol PARKHOSPS.
Park Hospital has made 2 acquisitions, including Nidaan Hospital, and RGS Healthcare.
Park Hospital is associated with 4 legal entities: Park Medi World Limited, Park Medicity (Haryana) Private Limited, Park Medicity India Private Limited and others.
The legal entities of Park Hospital currently have 13 directors, including Manju Sharma, Sanjay Sharma, Ajit Gupta and others.
